Provided by Tiger Fintech (Singapore) Pte. Ltd.

Werewolf Therapeutics, Inc.

1.19
-0.0200-1.65%
Pre-market: 1.190.00000.00%08:00 EDT
Volume:103.93K
Turnover:125.26K
Market Cap:53.40M
PE:-0.71
High:1.24
Open:1.21
Low:1.19
Close:1.21
Loading ...
Sep 18, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 28, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 23, 2023

Major Issues Report

8-K - Current report
Mar 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 22, 2023

Major Issues Report

8-K - Current report
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 17, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 17, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Major Issues Report

8-K - Current report
Jan 10, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 07, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 11, 2022

Major Issues Report

8-K - Current report